MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis

ConclusionsOur results might provide fundamentals for the development of new markers of the biological effects of IFN-β therapy.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research